Tags

Type your tag names separated by a space and hit enter

GeoSentinel: past, present and future†.
J Travel Med. 2020 12 23; 27(8)JT

Abstract

RATIONALE FOR REVIEW

In response to increased concerns about emerging infectious diseases, GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine in partnership with the US Centers for Disease Control and Prevention (CDC), was established in 1995 in order to serve as a global provider-based emerging infections sentinel network, conduct surveillance for travel-related infections and communicate and assist global public health responses. This review summarizes the history, past achievements and future directions of the GeoSentinel Network.

KEY FINDINGS

Funded by the US CDC in 1996, GeoSentinel has grown from a group of eight US-based travel and tropical medicine centers to a global network, which currently consists of 68 sites in 28 countries. GeoSentinel has provided important contributions that have enhanced the ability to use destination-specific differences to guide diagnosis and treatment of returning travelers, migrants and refugees. During the last two decades, GeoSentinel has identified a number of sentinel infectious disease events including previously unrecognized outbreaks and occurrence of diseases in locations thought not to harbor certain infectious agents. GeoSentinel has also provided useful insight into illnesses affecting different traveling populations such as migrants, business travelers and students, while characterizing in greater detail the epidemiology of infectious diseases such as typhoid fever, leishmaniasis and Zika virus disease.

CONCLUSIONS

Surveillance of travel- and migration-related infectious diseases has been the main focus of GeoSentinel for the last 25 years. However, GeoSentinel is now evolving into a network that will conduct both research and surveillance. The large number of participating sites and excellent geographic coverage for identification of both common and illnesses in individuals who have traversed international borders uniquely position GeoSentinel to make important contributions of travel-related infectious diseases in the years to come.

Authors+Show Affiliations

Department of Global Health, Boston University School of Public Health, Crosstown 308, 801 Massachusetts Avenue, Boston, MA 02118, USA. Section of Infectious Disease, Department of Medicine, Boston University School of Medicine, Crosstown 308, 801 Massachusetts Avenue, Boston, MA 02118, USA. National Emerging Infectious Disease Laboratory, Boston University, Crosstown 308, 801 Massachusetts Avenue, Boston, MA 02118, USA.GeoSentinel, International Society of Travel Medicine, 11720 Amber Park Drive, Suite 160, Alpharetta, GA 30009, USA.Division of Infectious Diseases, University of Alabama at Birmingham, 1720 2nd Ave S, BBRB 201, Birmingham, AL 35294 2170, USA.Division of Infectious Diseases (Emerita), Department of Medicine, Emory University, 2500 Peachtree Road NW, Suite 505, Atlanta, GA 30305, USA.J.D. MacLean Centre for Tropical Diseases, McGill University, Room E05.1830, 1001 Boulevard Décarie, Montréal, Québec H4A 3J1, Canada.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

Language

eng

PubMed ID

33247586

Citation

Hamer, Davidson H., et al. "GeoSentinel: Past, Present and Future†." Journal of Travel Medicine, vol. 27, no. 8, 2020.
Hamer DH, Rizwan A, Freedman DO, et al. GeoSentinel: past, present and future†. J Travel Med. 2020;27(8).
Hamer, D. H., Rizwan, A., Freedman, D. O., Kozarsky, P., & Libman, M. (2020). GeoSentinel: past, present and future†. Journal of Travel Medicine, 27(8). https://doi.org/10.1093/jtm/taaa219
Hamer DH, et al. GeoSentinel: Past, Present and Future†. J Travel Med. 2020 12 23;27(8) PubMed PMID: 33247586.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - GeoSentinel: past, present and future†. AU - Hamer,Davidson H, AU - Rizwan,Aisha, AU - Freedman,David O, AU - Kozarsky,Phyllis, AU - Libman,Michael, PY - 2020/11/14/received PY - 2020/11/17/revised PY - 2020/11/18/accepted PY - 2020/11/29/pubmed PY - 2021/1/21/medline PY - 2020/11/28/entrez KW - COVID-19 KW - Sentinel event KW - Zika KW - antimicrobial resistance KW - emerging infectious diseases KW - surveillance KW - travel medicine JF - Journal of travel medicine JO - J Travel Med VL - 27 IS - 8 N2 - RATIONALE FOR REVIEW: In response to increased concerns about emerging infectious diseases, GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine in partnership with the US Centers for Disease Control and Prevention (CDC), was established in 1995 in order to serve as a global provider-based emerging infections sentinel network, conduct surveillance for travel-related infections and communicate and assist global public health responses. This review summarizes the history, past achievements and future directions of the GeoSentinel Network. KEY FINDINGS: Funded by the US CDC in 1996, GeoSentinel has grown from a group of eight US-based travel and tropical medicine centers to a global network, which currently consists of 68 sites in 28 countries. GeoSentinel has provided important contributions that have enhanced the ability to use destination-specific differences to guide diagnosis and treatment of returning travelers, migrants and refugees. During the last two decades, GeoSentinel has identified a number of sentinel infectious disease events including previously unrecognized outbreaks and occurrence of diseases in locations thought not to harbor certain infectious agents. GeoSentinel has also provided useful insight into illnesses affecting different traveling populations such as migrants, business travelers and students, while characterizing in greater detail the epidemiology of infectious diseases such as typhoid fever, leishmaniasis and Zika virus disease. CONCLUSIONS: Surveillance of travel- and migration-related infectious diseases has been the main focus of GeoSentinel for the last 25 years. However, GeoSentinel is now evolving into a network that will conduct both research and surveillance. The large number of participating sites and excellent geographic coverage for identification of both common and illnesses in individuals who have traversed international borders uniquely position GeoSentinel to make important contributions of travel-related infectious diseases in the years to come. SN - 1708-8305 UR - https://www.unboundmedicine.com/medline/citation/33247586/GeoSentinel:_past_present_and_future†_ L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1093/jtm/taaa219 DB - PRIME DP - Unbound Medicine ER -